Vet Med - Czech, 2008, 53(3):153-164 | DOI: 10.17221/1942-VETMED

Model of septic shock induced by live E. coli (O18) in a laboratory rat

K. Dembovska1, P. Svoboda2, P. Scheer1, I. Kantorova2, J. Tomenendalova1, K. Rehakova1, J. Doubek1
1 Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Science, Brno, Czech Republic
2 Emergency Hospital, Brno, Czech Republic

This study was concerned with the development of induced septic shock in a laboratory rat using a series of measurements including body temperature, heart and respiratory rates, haematocrit value, red and white blood cell counts, differential leukocyte count, haemoglobin value, glycaemia, analysis of arterial blood gases, and serum levels of interleukin 6 (IL-6) during the first five hours. A total of 12 specific pathogen free (SPF) laboratory rats were used for the study. Septic shock was induced under general anaesthesia by introducing live E. coli (O18) into the jugular vein in the dose of 1 × 109 per 100 g of body weight (group SESH). Clinical measurements and blood collection from a. carotis were performed just prior to, and then 1.5 and 5 h after the administration of E. coli. The control group (C) contained 9 SPF laboratory rats which received physiological saline only, at the same volume into the jugular vein, and blood collection followed according to the same scheme as above described for group SESH. The results of the experiment showed that changes in clinical, haematological and biochemical parameters could be detected as early as 1.5 hours after induction. These changes correspond with the activation of an inflammatory reaction and the development of metabolic acidosis. They are accompanied by a considerable rise in IL-6 already 1.5 h after the application of live E. coli and after 5 h the levels exceeded 2 000 pg/ml in all experimental animals. Our results clearly document the importance of IL-6 for the early detection of developing septic shock and of some less specific but routinely determined parameters such as white blood cell count and base excess.

Keywords: sepsis; interleukin 6; systemic inflammatory response syndrome

Published: March 31, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dembovska K, Svoboda P, Scheer P, Kantorova I, Tomenendalova J, Rehakova K, Doubek J. Model of septic shock induced by live E. coli (O18) in a laboratory rat. Vet Med - Czech. 2008;53(3):153-164. doi: 10.17221/1942-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bone R.C., Balk R.A., Cerra F.B. (1992): American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine, 20, 864- 874. Go to original source... Go to PubMed...
    2. Borden E.C., Chin P. (1994): Interleukin-6: a cytokine with potential diagnostic and therapeutic roles. Journal of Laboratory Clinical Medicine, 123, 824-829.
    3. Calandra T., Gerain J., Heumann D., Baumgartner J.D., Glauser M.P. (1991): High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. American Journal of Medicine, 91, 23-29. Go to original source... Go to PubMed...
    4. Das U.N. (2003): Current advances in sepsis and septic shock with particular emphasis on the role of insulin. Medical Science Monitor, 9, RA181-192.
    5. Forfia P.R., Zhang X., Ochoa F., Ochoa M., Xu X., Bernstein R., Sehgal P.B., Ferreri N.R., Hintze T.H. (1998): Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs. American Journal of Physiology (Heart and Circulatory Physiology), 274, H193-201. Go to original source... Go to PubMed...
    6. Green E.M., Adams R. (1992): New perspectives in circulatory shock. Pathophysiologic mediators of mammalian response to endotoxemia and sepsis. Journal of American Veterinary Medical Association, 200, 1834-1841. Go to original source...
    7. Hack C.E., De Groot E.R., Felt-Bersma R.J.F., Nuijens J.H., Van Schijndel R.J.M.S., Eerenberg-Belmer A.J.M., Thijs L.G., Aarden L.A. (1989): Increased plasma levels of interleukin-6 in sepsis. Blood, 74, 1704- 710. Go to original source...
    8. Hammond R., Walters C. (1999): Monitoring the critical patient. In: King L., Hammond R. (eds.): BSAVA Manual of Canine and Feline Emergency and Critical Care. British Small Animal Veterinary Association, Dorset. 366 pp.
    9. Harbath S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., Vadas L., Pugin J. (2001): Diagnostic value of procalcitonin, interleukin 6 and interleukin 8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Critical Care Medicine, 164, 396-402. Go to original source... Go to PubMed...
    10. Haskins S.C. (1992): Management of septic shock. Journal of American Veterinary Medical Association, 200, 1915-1924. Go to original source...
    11. Hendricks J.C. (2003): Respiratory muscle fatigue and failure. In: King L.G. (ed.): Textbook for Respiratory Disease in Dogs and Cats. WB Saunders Co., Philadelphia. 61-66. Go to original source...
    12. Holden D.J., Hammond R. (1999): Anaesthesia and analgesia for the critical patient. In: King L., Hammond R. (eds.): BSAVA Manual of Canine and Feline Emergency and Critical Care. British Small Animal Veterinary Association, Dorset. 261-270.
    13. Jeschke M.G., Klein D., Herndon D.N. (2004): Insulin treatment improves the systemic inflammatory reaction to severe trauma. Annals of Surgery, 239, 553- 560. Go to original source... Go to PubMed...
    14. Johnson V., Gaynor A., Chan D.L., Rozanski E. (2004): Multiple organ dysfunction syndrome in humans and dogs. Journal of Veterinary Emergency and Critical Care, 14, 158-166. Go to original source...
    15. Kaplan P.M. (1992): Monitoring. In: Murtaugh R.J., Kaplan P.M. (eds.): Veterinary Emergency and Critical Care Medicine. Mosby-Year Book, St. Louis. 685 pp.
    16. Liaw Y.S., Yu C.J., Wu H.D., Yang P.C. (1997): Comparison of inflammatory cytokine concentration and physiologic parameters in septic shock. Journal of Formosan Medical Association, 96, 685-690.
    17. Marecaux G., Pinsky M.R., Dupont E., Kahn J.R., Vincent J.L. (1996): Blood lactate levels are better prognostic indicators than TNF and IL-6 in patients with septic shock. Intensive Care Medicine, 22, 404-408. Go to original source... Go to PubMed...
    18. Martin C., Saux P., Mege J.L., Perrin G., Papazian L., Gouin F. (1994): Prognostic values of serum cytokines in septic shock. Intensive Care Medicine, 20, 272- 277. Go to original source... Go to PubMed...
    19. Martin C., Boisson C., Haccoun M., Thomachot L., Mege J.L. (1997): Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Critical Care Medicine, 25, 1813-1819. Go to original source... Go to PubMed...
    20. Martin S.D., Mannino D.M., Eaton S., Moss M. (2003): The Epidemiology of sepsis in the United States from 1979 through 2000. New England Journal of Medicine, 348, 1546-1554. Go to original source... Go to PubMed...
    21. Martins G.A., Da Gloria Da Costa Carvalho M., Rocha Gattas C. (2003): Sepsis: a follow-up of cytokine production in different phases of septic patients. International Journal of Molecular Medicine, 11, 585-591. Go to original source...
    22. Moeniralam H.S., Bemelman W.A., Romijn J.A., Endert E., Ackermans M.T., van Lanschot J.B., Hermsen R.C., Sauerwein H.P. (1997): Origin of endotoxemia influences the metabolic response to endotoxin in dogs. Journal of Surgical Research, 73, 47-53. Go to original source... Go to PubMed...
    23. Muir W.W. (1999): Cardiopulmonary-cerebral resuscitation. In: King L., Hammond R. (eds.): BSAVA Manual of Canine and Feline Emergency and Critical Care. British Small Animal Veterinary Association, Dorset. 247-260.
    24. Pinsky M.R., Vincent J.L., Deviere J., Alegre M., Kahn R.J., Dupont E. (1993): Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest, 103, 565-575. Go to original source... Go to PubMed...
    25. Scheer P., Kosakova D., Doubek J. (2003): Medium term injection anaesthesia after ether induction in laboratory rat (in Czech). Ceskoslovenska Fyziologie, 52, 172-178. Go to PubMed...
    26. Smith I., Kumar P., Molloy S., Rhodes A., Newman P.J., Grounds R.M., Bennet E.D. (2001): Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Medicine, 27, 74-83. Go to original source... Go to PubMed...
    27. Tanaka J., Sato T., Jones R.T., Trump B.F., Cowley R.A. (1983): The pathophysiology of septic shock: responses to different doses of live Escherichia coli injection in rats. Advances in Shock Research, 9, 101-114. Go to PubMed...
    28. Taniguchi T., Kanakura H., Takemoto Y., Yamamoto K. (2003): Effects of hypothermia on mortality and inflammatory responses to endotoxin-induced shock in rats. Clinical and Diagnostic Laboratory Immunology, 10, 940-943. Go to original source... Go to PubMed...
    29. Vela A.I., Falsen E., Sinarro I., Rollan E., Collins M.D., Dominguez L., Fernandez-Garayzabal J.F. (2006): Neonatal mortality in puppies due to bacteriemia by Streptococcus dysgalactiae subsp. dysgalactiae. Journal of Clinical Microbiology, 44, 666-668. Go to original source... Go to PubMed...
    30. Yu W.K., Li W.Q., Li N., Li J.S. (2003): Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World Journal of Gastroenterology, 9, 1824-1827. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content